🔥🐔 BizChicken 🐔🔥
Companies Similar to BioAtla, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
Applied Therapeutics, Inc.
AT-007
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products targeting cardiovascular disease, galactosemia, and diabetic complications. Key products include AT-007 and AT-001.
About | Leadership | Leadership | Leadership | Leadership | Vision/Values | Culture | DEI | Contact | Contact | Careers | Careers | About | About | About
Symbol: APLT
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Shoshana Shendelman Ph.D.
Sector: Healthcare
Employees: 31
Address: 545 Fifth Avenue, New York, NY 10017
Phone: 212 220 9226
Leadership
- Shoshana Shendelman, Chair, Board of Directors
- Riccardo Perfetti, Chief Medical Officer
- Les Funtleyder,
- Dale Hooks, Chief Commercial Officer
- Constantine Chinoporos, Chief Business Officer / Chief Operating Officer
- Joel Marcus,
- Jay Skyler,
- Stacy Kanter,
- Teena Lerner,
- Donald Landry M.D., Ph.D., Chair, Scientific Advisory Board
- Roy Freeman M.D.,
- Roxana Mehran M.D.,
- Lawrence Steinman M.D.,
- Gregg Stone M.D.,
- Donald d'Amico M.D.,
- Donald Landry, Chair, Scientific Advisory Board
- Roy Freeman,
- Roxana Mehran,
- Lawrence Steinman,
- Gregg Stone,
- Donald d'Amico,
Last updated: 2024-12-31
AnaptysBio, Inc.
Imsidolimab, Rosnilimab, ANB032
Anaptys Bio, Inc. is a clinical stage biotechnology company focused on developing therapeutic product candidates for inflammation and immuno-oncology indications. Their products target dermatological inflammatory diseases and other human inflammatory conditions.
Symbol: ANAB
Recent Price: $13.22
Industry: Biotechnology
CEO: Mr. Daniel R. Faga
Sector: Healthcare
Employees: 117
Address: 10770 Wateridge Circle, San Diego, CA 92121-5801
Phone: 858 362 6295
Last updated: 2024-12-31
Atea Pharmaceuticals, Inc.
AT-527
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics for viral infections, with a lead product candidate AT-527 for COVID-19 treatment.
Symbol: AVIR
Recent Price: $3.33
Industry: Biotechnology
CEO: Dr. Jean-Pierre Sommadossi Ph.D.
Sector: Healthcare
Employees: 75
Address: 125 Summer Street, Boston, MA 02110
Phone: 857 284 8891
Leadership
- Jean-Pierre Sommadossi, PhD, FOUNDER, CHAIRMAN & CEO
- Nancy Agrawal, PhD, Executive VP, Preclinical Development
- Jonae Barnes, Senior VP, Investor Relations & Corporate Communications
- Bruce Belanger, PhD, Senior VP, Biostatistics
- Andrea Corcoran, CFO & Executive VP, Legal
- Adam DeZure, MD, VP, Clinical Development
- James MB Evans, PhD, VP, CMC Manufacturing
- Wayne Foster, EXECUTIVE VP, Chief Accounting Officer
- Kerry Gagnon, VP, Head of Quality
- Steven Good, EXECUTIVE VP, PRECLINICAL SCIENCE
- Janet Hammond, MD, PhD, CHIEF DEVELOPMENT OFFICER
- Arantxa Horga, MD, Chief Medical Officer
- Qi Huang, Senior VP, Virology
- Laura Ishak, Senior VP, Clinical Operations
- Ariyapadi Krishnaraj, VP, Marketing
- Adel Moussa, PhD, EXECUTIVE VP, CHEMISTRY
- Shari Noble, VP, Deputy General Counsel
- Keith Pietropaolo, Executive VP, Clinical Sciences and Project Management
- Brian Rowe, VP, Business Development
- Marc Van Hulle, VP, Finance
- John Vavricka, CHIEF COMMERCIAL OFFICER
- Alex Vo, PhD, VP, DMPK
- Jayanthi Wolf, PhD, Executive VP, Regulatory Affairs
- Xiao-Jian Zhou, PhD, EXECUTIVE VP, EARLY STAGE DEVELOPMENT
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Tyra Biosciences, Inc.
TYRA-300
Tyra Biosciences, Inc. is a preclinical-stage biopharmaceutical company focused on developing therapies to overcome tumor resistance and enhance outcomes for cancer patients. Its lead product candidate is TYRA-300, a selective inhibitor of FGFR3 for treating muscle invasive bladder cancer.
Symbol: TYRA
Recent Price: $13.90
Industry: Biotechnology
CEO: Dr. Todd Harris Ph.D.
Sector: Healthcare
Employees: 49
Address: 2656 State Street, Carlsbad, CA 92008
Phone: 619 728 4760
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
Artelo Biosciences, Inc.
ART27.13, ART12.11, ART26.12
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing treatments that modulate the endocannabinoid system, with a pipeline including treatments for cancer-related anorexia, inflammatory bowel disease, PTSD, prostate and breast cancer.
Symbol: ARTL
Recent Price: $1.05
Industry: Biotechnology
CEO: Mr. Gregory D. Gorgas M.B.A.
Sector: Healthcare
Employees: 5
Address: 505 Lomas Santa Fe, Solana Beach, CA 92075
Phone: 858 925 7049
Last updated: 2024-12-31
Atossa Therapeutics, Inc.
Endoxifen
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for oncology and infectious diseases with key programs in breast cancer and COVID-19 treatment.
Symbol: ATOS
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Steven C. Quay FCAP, M.D., Ph.D.
Sector: Healthcare
Employees: 12
Address: 107 Spring Street, Seattle, WA 98104
Phone: 206 588 0256
Last updated: 2024-12-31
Atara Biotherapeutics, Inc.
T-cell immunotherapy treatments
Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.
About | About | About | Contact | About | Careers | Careers | About | Careers | Careers | About | About
Symbol: ATRA
Recent Price: $13.28
Industry: Biotechnology
CEO: Dr. Anhco Nguyen Ph.D.
Sector: Healthcare
Employees: 165
Address: 611 Gateway Boulevard, South San Francisco, CA 94080
Phone: 650 278 8930
Last updated: 2024-12-31
Biora Therapeutics, Inc.
oral biotherapeutics
Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.
About | Leadership | About | Contact | Contact | Careers | Careers | About | Careers | Careers | About | About
Symbol: BIOR
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Aditya P. Mohanty M.B.A.
Sector: Healthcare
Employees: 58
Address: 4330 La Jolla Village Drive, San Diego, CA 92122
Phone: 855 293 2639
Leadership
- Adi Mohanty, MBA, Chief Executive Officer & Board Member
- Eric d’Esparbes, Chief Financial Officer
- Robyn Hatton, Head of Human Resources
- Ariella Kelman, MD, Chief Medical Officer
- James Knight, MBA, Head of Business Development
- Clarke Neumann, JD, General Counsel and Secretary
- Paul Shabram, MBA, Head of Technical Operations
- Sharat Singh, PhD, Head of Research
- Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
- Jeffrey Alter, MBA, Board Chair
- Jeffrey Ferrell, Board Member
- Jill Howe, Board Member
- Brian Kotzin, MD, Board Member
- Lynne Powell, MBA, Board Member
- Bruce Sands, MD, MS, Advisory Board Chair
- Geert D’Haens, MD, PhD, Advisory Board Member
- Brian Feagan, MD, FRCPC, Advisory Board Member
- Séverine Vermeire, MD, PhD, Advisory Board Member
- Satish Rao, MD, PhD, Advisory Board Chair
- William Chey, MD, Advisory Board Member
- Anthony Lembo, MD, Advisory Board Member
- Mark Pimentel, MD, Advisory Board Member
Last updated: 2024-12-31
Belite Bio, Inc
LBS-008
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.
Symbol: BLTE
Recent Price: $61.97
Industry: Biotechnology
CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.
Sector: Healthcare
Employees: 20
Address: 5820 Oberlin Drive, San Diego, CA 92121
Phone: 858-246-6240
Last updated: 2024-12-31
Immunovant, Inc.
batoclimab
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases, including batoclimab for myasthenia gravis and thyroid eye disease.
Symbol: IMVT
Recent Price: $23.88
Industry: Biotechnology
CEO: Dr. Peter Salzmann M.B.A., M.D.
Sector: Healthcare
Employees: 207
Address: 320 West 37th Street, New York, NY 10018
Phone: 917 580 3099
Leadership
- Pete Salzmann, M.D., MBA, Chief Executive Officer
- Renee Barnett, MBA, Chief Financial Officer
- Christine Blodgett, Senior Vice President of Human Resources
- Andy Deig, Senior Vice President Strategic Finance
- Michael Geffner M.D., MBA, Chief Medical Officer
- Julie Kirschling, Senior Vice President, Program and Alliance Management
- Mark Levine, Chief Legal Officer and Corporate Secretary
- Bill Macias, M.D., Ph.D., Chief Medical Officer
- Becky Merlina, Senior Vice President, Global Head of Quality
- Jody Roth, MS, RAC, PMP, Senior Vice President, Regulatory Affairs
- Jay S. Stout, PhD, Chief Technology Officer
- Yan Zheng, Ph.D., Senior Vice President Biostatistics, Programming & Data Management
- Chandra Adams, Vice President, Associate General Counsel
- Maria Alba, M.D., Vice President of Clinical Development
- Farah Ali, Vice President, Clinical Development
- Jennifer Ashley, Vice President, Associate General Counsel
- Annetta Beauregard, Vice President, Regulatory Affairs Strategy
- Harry Berlanga, MSc., VP, CMC & Distribution Quality
- Ranjit Deshmukh, Ph.D., Vice President of CMC and Technical Operations
- Scott Forman, MBA, Vice President, Program Management
- Tom Forman, MBA, Vice President, CMC Project Management
- Ian Gourley, M.D., Vice President of Clinical Development
- Thomas Hardy, M.D., Ph.D., Vice President of Drug Safety and Pharmacovigilance
- Laci Hasenour, Vice President Marketing, Neurology
- Aileen Ilaria, MBA, Vice President, Clinical Operations – Global Site Management
- Claudia Jacobs, Ph.D., Vice President of CMC Project Management Operations and Clinical Supply
- Jonathan Janes, MB, Vice President Clinical Development
- Ant Kidwell, Vice President of IT and Facilities
- Chedvi Levin-Sister, Vice President of Finance
- Launi Masterson, Vice President of Clinical Operations
- Andy Minke, Vice President Program Management
- Linda McKerral, Vice President, CMC Analytical Sciences
- Pooja Mehta, Vice President Drug Substance Tech Transfer
- Regina Mirra, VP, Regulatory Operational Excellence
- Jennifer Moseley, Vice President of Clinical Operations
- Sheetal Patel M.D., MS MBA, Vice President of Clinical Development
- Cassandra Pauyo, Vice President, Data Management
- Rod Saponjic Ph.D., MBA, Vice President of Clinical Operations
- Lauren Schrier, MBA, Vice President of Marketing
- Frank Torti, M.D., Chairperson of Board of Directors
- Andrew Fromkin, Member of Board of Directors
- Douglas Hughes, Member of Board of Directors
- George Migausky, Member of Board of Directors
- Atul Pande, M.D., Member of Board of Directors
- Eric Venker, M.D., Pharm.D., Member of Board of Directors
Last updated: 2024-12-31
Ocean Biomedical, Inc.
Humanized Monoclonal Antibodies, Small Molecule Candidates, Malaria Vaccine
Ocean Biomedical, Inc. is a biopharmaceutical company that develops therapeutic products for oncology, fibrosis, infectious diseases, and inflammation, with a focus on innovative treatments like monoclonal antibodies targeting Chi3l1 and small molecules targeting Chit1.
Symbol: OCEA
Recent Price: $0.60
Industry: Biotechnology
CEO: Dr. Jack A. Elias M.D.
Sector: Healthcare
Employees: 9
Address: Room 325, 55 Claverick Street, Providence, RI 02903
Phone: 401-444-7375
Last updated: 2024-12-31
Palisade Bio, Inc.
LB1148
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral therapies targeting serious diseases related to the breakdown of the gastrointestinal mucosal barrier. Their lead product, LB1148, is designed to protect gut integrity during intestinal stress.
Symbol: PALI
Recent Price: $1.70
Industry: Biotechnology
CEO: Mr. J. D. Finley
Sector: Healthcare
Employees: 9
Address: 5800 Armada Drive, Carlsbad, CA 92008
Phone: 858 704 4900
Last updated: 2024-12-31
SAB Biotherapeutics, Inc.
SAB-185, SAB-176
SAB Biotherapeutics is a clinical-stage biopharmaceutical company focusing on developing immunotherapies based on human antibodies, using advanced genetic engineering to produce fully-human polyclonal antibodies targeting diseases such as COVID-19, influenza, autoimmune disorders, and cancer.
Symbol: SABS
Recent Price: $4.15
Industry: Biotechnology
CEO: Mr. Samuel J. Reich
Sector: Healthcare
Employees: 57
Address: 2100 East 54th Street North, Sioux Falls, SD 57104
Phone: 605 679 6980
Last updated: 2024-12-31
Sana Biotechnology, Inc.
N/A
Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.
Symbol: SANA
Recent Price: $1.61
Industry: Biotechnology
CEO: Dr. Steven D. Harr M.D.
Sector: Healthcare
Employees: 328
Address: 188 East Blaine Street, Seattle, WA 98102
Phone: 206 701 7914
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31